ISSN: 2161-0495
+44 1478 350008
Interno de Formação específica de Medicina Interna, Centro Hospitalar de Lisboa Central EPE, Serviço de Medicina Interna, Lisboa, Portugal
Commentary
Subacute Cutaneous Lupus Secondary to Trastuzumab Emtasine
Author(s): Joao Alves Teixeira*, Costa Catarina, Santos Ines and Janeiro Claudia
There is a defined, but poorly described, relationship between Trastuzumab and Cutaneous Lupus Erythematosus,
and whether Trastuzumab causes CLE or simply leads to dermatologic manifestations of latent Lupus Erythematosus
has yet to be established. The link between the two seems now more relevant than ever, as Trastuzumab has recently
been theorized as a possible therapy for Lupus Nephritis. As such, any cutaneous rash or skin lesion that appears
after the administration of Trastuzumab should lead to suspicion of Cutaneous Lupus Erythematosus. We report a
case of Cutaneous Lupus Erythematosus, proven by both skin biopsy and serology, in a female patient on her 9th
cycle of Trastuzumab emtasine for breast cancer... View More»
DOI:
10.35248/2161-0495.21.s19.005